A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

NCT01426113 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to corporate decision.

Conditions

Glaucoma

Interventions

DRUG: bimatoprost ophthalmic solution formulation A
DRUG: timolol ophthalmic solution
DRUG: bimatoprost vehicle

Sponsor

Allergan